汉邦科技 (688755)
Jiangsu Hanbon Science and Technology Co., Ltd.
K-Line Chart
No K-line data available
Company NameJiangsu Hanbang Technology Co., Ltd.
Listing Date2025-05-16
Issue Price22.77RMB
Registered Capital880010k RMB
Legal RepresentativeZhang Dabing
Registered AddressNo. 10 Xinzhu Road, Huaian Economic and Technological Development Zone, Jiangsu Province; No. 1-9 Jixian Road, Huaian Economic and Technological Development Zone (This location shall not engage in business activities involving hazardous chemicals or other activities requiring administrative permits) (Multiple addresses under one license)
IndustryMedical Devices
Main BusinessA high-tech enterprise with chromatography technology at its core, integrating R&D, production, and sales. It primarily provides professional separation and purification equipment, consumables, application technical services, and related technical solutions for fields such as pharmaceuticals and life sciences.
Company ProfileJiangsu Hanbang Technology Co., Ltd. is a high-tech enterprise with chromatography technology at its core, integrating R&D, production, and sales. It primarily provides professional separation and purification equipment, consumables, application technical services, and related technical solutions for fields such as pharmaceuticals and life sciences.
The company has been granted a total of 36 invention patents, including 27 domestic invention patents and 9 overseas invention patents. It has presided over or led 15 provincial-level or above scientific research and industrialization projects, including 6 national-level projects such as the National Major Scientific Instrument and Equipment Development Project "Development and Application of Supercritical Fluid Chromatograph" and the National Technology-based SME Technology Innovation Fund Project "Simulated Moving Bed Chromatography Separation and Purification Device for Drug Preparation." The company has successively been awarded honors such as National Intellectual Property Demonstration Enterprise and National Specialized, Refined, Distinctive, and Innovative "Little Giant" Enterprise.
Stock Details
1. Key Indicators
- Total Shares(W): 8800.00
- Circulating A-Shares(W): 1760.00
- Earnings Per Share(RMB): 0.4900
- Net Assets Per Share(RMB): 13.8122
- Operating Revenue(W RMB): 50575.05
- Total Profit(W RMB): 4298.15
- **Net Profit Attributable to Parent(W RMB) **: 3701.72
- Net Profit Growth Rate(%): -17.27
- Weighted Return on Equity(%): 3.8600
- Operating Cash Flow Per Share(RMB): 0.6540
- Undistributed Profit Per Share(RMB): 1.9584
- Capital Reserve Per Share(RMB): 10.5245
2. Main Business
The main business covers:
- R&D, production and sales of chromatography technology
3. Company Basic Information
- Company Name: Jiangsu Hanbon Science & Technology Co., Ltd.
- Listing Date: 2025-05-16
- Industry: Special Purpose Equipment Manufacturing
- Address: No. 10 Xinzhu Road, Huaian Economic and Technological Development Zone, Jiangsu Province; No. 1-9 Jixian Road, Huaian Economic and Technological Development Zone
- Website: https://www.hanbon.com.cn
- Company Profile: Hanbon Science & Technology was established as a joint stock company through the overall change of Hanbon Limited. It is primarily engaged in the R&D, production, and sales of chromatography technology. The company was founded in February 2022 and is headquartered in Huaian City, Jiangsu Province.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Bosera Xinxiang One-Year Holding Mixed Securities Investment Fund Class A | Fund | 0.02 | 0.00 |
| 2 | Great Wall CSI A500 Index Securities Investment Fund Class A | Fund | 0.02 | 0.00 |
| 3 | Fullgoal SSE STAR Market 100 Index Initiation Securities Investment Fund Class A | Fund | 0.02 | 0.00 |
| 4 | Fullgoal SSE STAR Market 50 Constituents ETF联接 Fund Class A | Fund | 0.02 | 0.00 |
| 5 | Fullgoal SSE STAR Market Composite Price ETF | Fund | 0.02 | 0.00 |
| 6 | Fullgoal CSI A100 ETF | Fund | 0.02 | 0.00 |
| 7 | Fullgoal CSI Shanghai-Hong Kong-Shenzhen 500 ETF | Fund | 0.02 | 0.00 |
| 8 | Fullgoal CSI Central Enterprise Innovation Driven ETF | Fund | 0.02 | 0.00 |
| 9 | ICBC Credit Suisse SSE 50 ETF | Fund | 0.02 | 0.00 |
| 10 | ICBC Credit Suisse SSE STAR Market Bio-Medicine ETF | Fund | 0.02 | 0.00 |
5. Concept Sectors
- Secondary New Stock
- Margin Trading & Securities Lending
- Approaching Lifting of Sales Restrictions
- High Margin Financing
- Specialized, Refined, Peculiar, and New
- STAR Market Secondary New Stock
Remarks
- Data update date: 2025-11-10
- Data source: Public Market Information